$2.25
0.07[3.21%]
At close: Apr 26
$2.25
0[0.00%]
After Hours: 8:29AM EDT
Indaptus Therapeutics: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Aug 16, 2023 | Glen R Anderson | 10% OWNER | 103.352K | $2.09 | $216.39K | BUY | 9.51% | 1.1904M | Aug 10 - Aug 14 | View |
Dec 19, 2022 | Boyan Litchev | CHIEF MEDICAL OFFICER | 1.15K | $2.19 | $2.52K | BUY | ∞ | 1.15K | Jan 31 - Dec 01 | View |
Nov 22, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 10K | $1.89 | $18.95K | BUY | 15.30% | 75.374K | Nov 18 - Nov 21 | View |
Sep 12, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 10.308K | $2.80 | $28.86K | BUY | 18.72% | 65.374K | Sep 08 | View |
Sep 09, 2022 | Walt Linscott | CHIEF BUSINESS OFFICER | 150 | $2.62 | $393.00 | BUY | ∞ | 150 | Sep 07 | View |
Sep 08, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 9.692K | $2.56 | $24.77K | BUY | 21.36% | 55.066K | Sep 06 - Sep 07 | View |
Jun 07, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 19.727K | $2.63 | $51.88K | BUY | 76.92% | 45.374K | Jun 06 | View |
Feb 02, 2022 | Michael Newman | CSO AND DIRECTOR | -20K | $5.00 | -$100.04K | SELL | -1.44% | 1.368356M | Jan 31 - Feb 01 | View |
Nov 19, 2021 | Jeffrey Meckler | CEO AND DIRECTOR | 11.187K | $5.82 | $65.11K | BUY | 77.37% | 25.647K | Nov 18 | View |
Sep 16, 2021 | Jeffrey Meckler | CEO AND DIRECTOR | 12K | $7.00 | $84.00K | BUY | 487.80% | 14.46K | Sep 14 | View |
Browse insider trades on all stocks.